Time to ACT: launching an Addiction Care Team (ACT) in an urban safety-net health system.


Journal

BMJ open quality
ISSN: 2399-6641
Titre abrégé: BMJ Open Qual
Pays: England
ID NLM: 101710381

Informations de publication

Date de publication:
01 2021
Historique:
received: 08 07 2020
revised: 02 01 2021
accepted: 10 01 2021
entrez: 27 1 2021
pubmed: 28 1 2021
medline: 30 9 2021
Statut: ppublish

Résumé

Across the USA, morbidity and mortality from substance use are rising as reflected by increases in acute care hospitalisations for substance use complications and substance-related deaths. Patients with substance use disorders (SUD) have long and costly hospitalisations and higher readmission rates compared to those without SUD. Hospitalisation presents an opportunity to diagnose and treat individuals with SUD and connect them to ongoing care. However, SUD care often remains unaddressed by hospital providers due to lack of a systems approach and addiction medicine knowledge, and is compounded by stigma. We present a blueprint to launching an interprofessional inpatient addiction care team embedded in the hospital medicine division of an urban, safety-net integrated health system. We describe key factors for successful implementation including: (1) demonstrating the scope and impact of SUD in our health system via a needs assessment; (2) aligning improvement areas with health system leadership priorities; (3) involving executive leadership to create goal and initiative alignment; and (4) obtaining seed funding for a pilot programme from our Medicaid health plan partner. We also present challenges and lessons learnt.

Identifiants

pubmed: 33500326
pii: bmjoq-2020-001111
doi: 10.1136/bmjoq-2020-001111
pmc: PMC7843300
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

JAMA Netw Open. 2020 Feb 5;3(2):e1921451
pubmed: 32083687
J Addict Med. 2012 Mar;6(1):50-6
pubmed: 21979821
JAMA Netw Open. 2020 Sep 1;3(9):e2022942
pubmed: 32990735
J Hosp Med. 2018 Apr 25;13(11):752-758
pubmed: 29694454
J Gen Intern Med. 2017 Aug;32(8):909-916
pubmed: 28526932
J Addict Med. 2019 Mar/Apr;13(2):104-112
pubmed: 30608266
JAMA Intern Med. 2014 Aug;174(8):1369-76
pubmed: 25090173
J Hosp Med. 2017 May;12(5):339-342
pubmed: 28459904
J Subst Abuse Treat. 2017 Aug;79:1-5
pubmed: 28673521
NCHS Data Brief. 2020 Jan;(356):1-8
pubmed: 32487285

Auteurs

Marlene Martin (M)

Department of Medicine, University of California, San Francisco and San Francisco General Hospital, San Francisco, California, USA marlene.martin@ucsf.edu.

Hannah R Snyder (HR)

Department of Family and Community Medicine, University of California, San Francisco and San Francisco General Hospital, San Francisco, CA, USA.

Diana Coffa (D)

Department of Family and Community Medicine, University of California, San Francisco and San Francisco General Hospital, San Francisco, CA, USA.

Scott Steiger (S)

Department of Medicine, University of California, San Francisco and San Francisco General Hospital, San Francisco, California, USA.

Joseph P Clement (JP)

Department of Nursing, San Francisco General Hospital, San Francisco, California, USA.

Sumant R Ranji (SR)

Department of Medicine, University of California, San Francisco and San Francisco General Hospital, San Francisco, California, USA.

Soraya Azari (S)

Department of Medicine, University of California, San Francisco and San Francisco General Hospital, San Francisco, California, USA.

Oanh K Nguyen (OK)

Department of Medicine, University of California, San Francisco and San Francisco General Hospital, San Francisco, California, USA.

Paula J Lum (PJ)

Department of Medicine, University of California, San Francisco and San Francisco General Hospital, San Francisco, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH